CVS Health to hold third quarter 2025 earnings conference call
CVS Health (NYSE: CVS) has scheduled its third quarter 2025 earnings conference call for Wednesday, October 29th, 2025, at 8:00 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CVS Health (NYSE: CVS) has scheduled its third quarter 2025 earnings conference call for Wednesday, October 29th, 2025, at 8:00 a.m. ET. During this call, the company will discuss its Q3 2025 financial performance with analysts and investors.
The event will be accessible through an audio webcast on the Investor Relations section of CVS Health's website at investors.cvshealth.com. The webcast recording will remain available for replay on the website for one year following the event.
Details
News Market Reaction – CVS
On Sep 30, the day this news came out, CVS closed 0.24% below the previous close.
Data tracked by StockTitan Argus for the Sep 30 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year.
About CVS Health
CVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of June 30, 2025, the Company had approximately 9,000 retail locations, more than 1,000 walk-in and primary care medical clinics, a leading pharmacy benefits manager with approximately 87 million plan members and expanding specialty pharmacy solutions. The Company also serves an estimated more than 37 million people through traditional, voluntary and consumer-directed health insurance products and related services, including highly rated Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company's integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.
Media contact
Ethan Slavin
860-273-6095
SlavinE@cvshealth.com
Investor contact
Larry McGrath
800-201-0938
investorinfo@cvshealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/cvs-health-to-hold-third-quarter-2025-earnings-conference-call-302570158.html
SOURCE CVS Health
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.